Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Mar;27(1):309-318.
doi: 10.1007/s11325-022-02572-8. Epub 2022 Feb 9.

Comparative efficacy of prolonged-release melatonin versus clonazepam for isolated rapid eye movement sleep behavior disorder

Jung-Ick Byun #  1   2 , Yu Yong Shin #  2 , Yoon-Ah Seong  1 , Seon-Min Yoon  1 , Kyoung Jin Hwang  2 , Yu Jin Jung  3 , Kwang Su Cha  4 , Ki-Young Jung  4 , Won Chul Shin  5   6
Affiliations
Randomized Controlled Trial

Comparative efficacy of prolonged-release melatonin versus clonazepam for isolated rapid eye movement sleep behavior disorder

Jung-Ick Byun et al. Sleep Breath. 2023 Mar.

Abstract

Purpose: Clonazepam and melatonin are recommended as first-line treatments for isolated rapid eye movement (REM) sleep behavior disorder (iRBD). This study aimed to compare their efficacy and safety in REM sleep without atonia (RWA) and RBD-related symptoms.

Methods: This prospective, open-label, randomized trial included patients with video-polysomnography-confirmed iRBD. The patients were randomly assigned to receive either clonazepam 0.5 mg or prolonged-release (PR) melatonin 2 mg 30 min before bedtime for 4 weeks. The primary outcome was changes in RWA on follow-up polysomnography (PSG). Secondary endpoints were changes in other PSG parameters, clinical global improvement-impression scale (CGI-I) scores, and sleep questionnaire scores. The safety endpoint was adverse events.

Results: Of 40 patients with probable RBD considered, 34 were enrolled in the study and randomized. Visual scoring parameters of RWA indices were reduced, and automatic scoring parameters tended to be improved after clonazepam treatment but not after PR melatonin treatment. The proportion of N2 sleep was increased, and N3 and REM sleep were decreased only in the clonazepam group. The clonazepam group tended to answer "much or very much improvement" on the CGI-I more frequently than the PR melatonin group (p = 0.068). Daytime sleepiness and insomnia symptoms were reduced after PR melatonin but not after clonazepam. Depressive symptoms increased after clonazepam. Four of the patients (13.3%) reported mild to moderate adverse events, which were similar between the two groups.

Conclusion: Four weeks of clonazepam, but not PR melatonin, improved RWA. RBD symptom improvement tended to be better after clonazepam than PR melatonin in exchange for increased depressive symptoms and daytime sleepiness.

Clinicaltrials: gov identifier: NCT03255642 (first submitted August 21, 2017).

Keywords: Clonazepam; Efficacy; Melatonin; REM sleep behavior disorder; Treatment.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Schenck CH et al (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9(2):293–308 - DOI - PubMed
    1. McCarter SJ et al (2014) Factors associated with injury in REM sleep behavior disorder. Sleep Med 15(11):1332–1338 - DOI - PubMed - PMC
    1. Ferri R et al (2013) Effects of long-term use of clonazepam on nonrapid eye movement sleep patterns in rapid eye movement sleep behavior disorder. Sleep Med 14(5):399–406 - DOI - PubMed
    1. Peever J, Luppi PH, Montplaisir J (2014) Breakdown in REM sleep circuitry underlies REM sleep behavior disorder. Trends Neurosci 37(5):279–288 - DOI - PubMed
    1. Lee HJ, Choi H, Yoon IY (2021) Age of diagnosis and comorbid PLMD predict poor response of REM behavior disorder to clonazepam. J Geriatr Psychiatry Neurol 34(2):142–149 - DOI - PubMed

Publication types

Associated data

LinkOut - more resources